BRIACELL THERAPEUTICS CORP. (BCTXZ) Free cash flow 2024–2026
BRIACELL THERAPEUTICS CORP. (BCTXZ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.8MFY2026 · since FY2024: -$24.6M → -$28.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.8M | — |
| FY2024 | -$24.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXZ financial trends
BCTXZ RevenueBCTXZ Net incomeBCTXZ Net marginBCTXZ Gross profitBCTXZ Gross marginBCTXZ Operating incomeBCTXZ Operating marginBCTXZ Operating cash flowBCTXZ Capital expendituresBCTXZ Return on equityBCTXZ Stock buybacksBCTXZ Dividends paidBCTXZ Total assetsBCTXZ Total liabilitiesBCTXZ Shareholders’ equityBCTXZ overview →